COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Vitamin D study #12 of 69
7/23 Analysis of outcomes based on serum levels
Merzon et al., The FEBS Journal, doi:doi.org/10.1111/febs.15495 (Peer Reviewed)
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
Source   PDF   Share   Tweet
Analysis of 7,807 patients finding that low vitamin D levels are correlated with increased risk of cases and hospitalization. Adjusted odds ratio OR for sufficient vitamin D level for cases 0.69, p < 0.001, and for hospitalization 0.51, p = 0.061.

Merzon et al., 7/23/2020, retrospective, Israel, Middle East, peer-reviewed, 3 authors.
risk of hospitalization, 46.4% lower, RR 0.54, p = 0.06, high D levels 79, low D levels 703, odds ratio converted to relative risk, >30ng/mL.
risk of COVID-19 case, 28.4% lower, RR 0.72, p < 0.001, high D levels 1139, low D levels 6668, odds ratio converted to relative risk, >30ng/mL.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 69 studies
Please send us corrections, updates, or comments.
Submit